Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2019 Sep 4;123(6):595–601.e1. doi: 10.1016/j.anai.2019.08.018

Table 3:

The association of rs1898671 and remission in the full PEER cohort and among those who are African-American and white and based on the presence of FLG LoF. The odd ratios are adjusted for age onset, sex, race if appropriate and the presence of FLG LoF when appropriate.

PEER:
White or
African-
American		 FLG LoF No FLG LoF
Combined 1.56
(1.26,1.91)
p<0.0001
N=705		 1.98
(1.33,2.98)
p=0.001
N=170		 1.43
(1.12,1.82)
p=0.003
N=535
White 1.20
(0.94,1.53)
N=379		 1.81
(1.16,2.84)
p=0.007
N=120		 1.19
(0.94,1.53)
N=259
African-American 1.83
(1.12,2.98)
p=0.018
N=326		 _______*
N=50		 1.94
(1.18,3.20)
p=0.011
N=276
*

insufficient sample for estimate.